A subsequent qPCR based screening in 503 NPM1-mutant AML patients confirmed a broad range of PRDM16 mRNA copy numbers: median 1692 (range, 1–89,845) (95%-CI, 1321–1948) (Fig. 1B). The gene discussed is NPM1; the disease is acute myeloid leukemia.